StockData
Profound Medical Corp. logo

Profound Medical Corp. (PROF) income statement

PROFNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/30
$7.08−0.26 (-3.54%)

Close on Nov 17, 2026Market cap $258.65MP/E –Yield –

Profound Medical Corp. income statement

Ratios

Latest available, balances at Jun 30, 2026

Profitability, TTM

Gross margin
71.8%
Operating margin
-185.3%
Net margin
-171.6%
Return on equity, FY2025
-67.1%

Financial strength

Current ratio
6.46
Debt to equity
–
Debt to assets
–
Cash to current liabilities
420.0%

Valuation

P/E ratio
–
Price to sales
13.55
Price to book
5.19
Dividend yield
–

See a number that looks wrong?